Advertisement

Wiener klinische Wochenschrift

, Volume 122, Supplement 1, pp 1–3 | Cite as

Tropical Medicine at the University of Tübingen

  • Peter Gottfried Kremsner
Editorial
  • 174 Downloads

References

  1. Ramharter M, Adegnika AA, Agnandji ST, Matsiegui BP, Grobusch MP, Winkler S, et al (2007) History and perspectives of medical research at the Albert Schweitzer Hospital in Lambaréné, Gabon. Wien Klin Wochenschr 119[Suppl 3]: 8–12CrossRefPubMedGoogle Scholar
  2. Bouyou-Akotet MK, Mawili-Mboumba DP, Kendjo E, Mabika-Mamfoumbi M, Ngoungou EB, Dzeing-Ella A, et al (2009) Evidence of decline of malaria in the general hospital of Libreville, Gabon from 2000 to 2008. Malaria J 8: 300CrossRefGoogle Scholar
  3. Hamm DM, Agossou A, Gantin RG, Kocherscheidt L, Banla M, Dietz K, et al (2009) Coinfections with Schistosoma haematobium, Necator americanus, and Entamoeba histolytica/Entamoeba dispar in children: chemokine and cytokine responses and changes after antiparasite treatment. J Infect Dis 199: 1583–91CrossRefPubMedGoogle Scholar
  4. Kremsner PG, Winkler S, Brandts C, Neifer S, Bienzle U, Graninger W (1994) Clindamycin in combination with Chloroquine or Quinine is an effective therapy for uncomplicates Plasmodium-falciparum malaria in children from Gabon. J Infect Dis 169: 467–70CrossRefPubMedGoogle Scholar
  5. Kremsner PG, Radloff P, Metzger W, Wildling E, Mordmüller B, Philipps J, et al (1995) Quinine plus Clindamycin improves chemotherapy of severe malaria in children. Antimicrob Agents Chemother 39: 1603–5CrossRefPubMedPubMedCentralGoogle Scholar
  6. Ramharter M, Oyakhirome S, Klein Klouwenberg P, Adégnika AA, Agnandji ST, Missinou MA, et al (2005) Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial. Clin Infect Dis 40: 1777–84CrossRefPubMedGoogle Scholar
  7. Radloff PD, Philipps J, Nkeyi M, Hutchinson D, Kremsner PG (1996) Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet 347: 1511–4CrossRefPubMedGoogle Scholar
  8. Borrmann S, Faucher JF, Bagaphou T, Missinou MA, Binder RK, Pabisch S, et al (2003) Atovaquone and proguanil versus amodiaquine for the treatment of Plasmodium falciparum malaria in African infants and young children. Clin Infect Dis 37: 1441–7CrossRefPubMedGoogle Scholar
  9. Lell B, Luckner D, Ndjavé M, Scott T, Kremsner PG (1998) Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children. Lancet 351: 709–13CrossRefPubMedGoogle Scholar
  10. Faucher JF, Binder R, Missinou MA, Matsiegui PB, Gruss H, Neubauer R, et al (2002) Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines. Clin Infect Dis 35: 1147–54CrossRefPubMedGoogle Scholar
  11. Lell B, Faucher JF, Missinou MA, Borrmann S, Dangelmaier O, Horton J, et al (2000) Malaria chemoprophylaxis with tafenoquine: a randomised study. Lancet 355: 2041–5CrossRefPubMedGoogle Scholar
  12. Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, et al (2002) Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet 359: 1365–72CrossRefPubMedGoogle Scholar
  13. Alloueche A, Bailey W, Barton S, Bwika J, Chimpeni P, Falade CO, et al (2004) Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial. Lancet 363: 1843–8CrossRefPubMedGoogle Scholar
  14. Kremsner PG, Krishna S (2004) Antimalarial combinations. Lancet 364: 285–94CrossRefPubMedGoogle Scholar
  15. Missinou MA, Borrmann S, Schindler A, Issifou S, Adegnika AA, Matsiegui PB, et al (2002) Fosmidomycin for malaria. Lancet 360: 1941–2CrossRefPubMedGoogle Scholar
  16. Borrmann S, Adegnika AA, Matsiegui PB, Issifou S, Schindler A, Mawili-Mboumba DP, et al (2004) Fosmidomycin-clindamycin for Plasmodium falciparum infections in African children. J Infect Dis 189: 901–8CrossRefPubMedGoogle Scholar
  17. Borrmann S, Issifou S, Esser G, Adegnika AA, Ramharter M, Matsiegui PB, et al (2004) Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria. J Infect Dis 190: 1534–40CrossRefPubMedGoogle Scholar
  18. Borrmann S, Lundgren I, Oyakhirome S, Impouma B, Matsiegui PB, Adegnika AA, et al (2006) Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria. Antimicrob Agents Chemother 50: 2713–8CrossRefPubMedPubMedCentralGoogle Scholar
  19. Oyakhirome S, Issifou S, Pongratz P, Barondi F, Ramharter M, Kun JF, et al (2007) Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria. Antimicrob Agents Chemother 51: 1869–71CrossRefPubMedPubMedCentralGoogle Scholar
  20. Grobusch MP, Lell B, Schwarz NG, Gabor J, Dornemann J, Potschke M, et al (2007) Intermittent preventive treatment against malaria in infants in Gabon – a randomized, double-blind, placebo-controlled trial. J Infect Dis 196: 1595–602CrossRefPubMedGoogle Scholar
  21. Grobusch MP, Gabor JJ, Aponte JJ, Schwarz NG, Poetschke M, Doernemann J, et al (2009) No rebound of morbidity following intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Gabon. J Infect Dis 200: 1658–61CrossRefPubMedGoogle Scholar
  22. Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, et al (2009) Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet 374: 1533–42CrossRefPubMedGoogle Scholar
  23. Oliveira GA, Wetzel K, Calvo-Calle JM, Nussenzweig R, Schmidt A, Birkett A, et al (2005) Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial. Infect Immun 73: 3587–97CrossRefPubMedPubMedCentralGoogle Scholar
  24. Esen M, Kremsner PG, Schleucher R, Gässler M, Imoukhuede EB, Imbault N, et al (2009) Safety and immunogenicity of GMZ2 – a MSP3-GLURP fusion protein malaria vaccine candidate. Vaccine 27: 6862–8CrossRefPubMedGoogle Scholar
  25. Lell B, Agnandji S, von Glasenapp I, Haertle S, Oyakhiromen S, Issifou S, et al (2009) A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon. PLoS One 4: e7611CrossRefPubMedPubMedCentralGoogle Scholar
  26. Taylor T, Olola C, Valim C, Agbenyega T, Kremsner P, Krishna S, et al (2006) Standardized data collection for multi-center clinical studies of severe malaria in African children: establishing the SMAC network. Trans R Soc Trop Med Hyg 100: 615–22CrossRefPubMedPubMedCentralGoogle Scholar
  27. Kremsner PG, Valim C, Missinou MA, Olola C, Krishna S, Issifou S, et al (2009) Prognostic value of circulating pigmented cells in African children with malaria. J Infect Dis 199: 142–50CrossRefPubMedPubMedCentralGoogle Scholar
  28. Helbok R, Issifou S, Matsiegui PB, Lackner P, Missinou MA, Kombila D, et al (2006) Simplified multi-organ dysfunction score predicts disability in African children with Plasmodium falciparum malaria. Am J Trop Med Hyg 2006: 443–7Google Scholar
  29. Helbok R, Kendjo E, Issifou S, Lackner P, Newton CR, Kombila M, et al (2009) The Lambaréné Organ Dysfunction Score (LODS) is a simple clinical predictor of fatal malaria in African children. J Infect Dis 200: 1834–41CrossRefPubMedGoogle Scholar
  30. Kun JF, Schmidt-Ott RJ, Lehman LG, Lell B, Luckner D, Greve B, et al (1998) Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambaréné, Gabon. Trans R Soc Trop Med Hyg 92: 110–4CrossRefPubMedGoogle Scholar
  31. Kun JF, Mordmüller B, Lell B, Lehman LG, Luckner D, Kremsner PG (1998) Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 351: 265–6CrossRefPubMedGoogle Scholar
  32. Kun JF, Mordmüller B, Perkins DJ, May J, Mercereau-Puijalon O, Alpers M, et al (2001) Nitric oxide synthase 2(Lambaréné) (G-954C), increased nitric oxide production, and protection against malaria. J Infect Dis 184: 330–6CrossRefPubMedGoogle Scholar
  33. Luty AJ, Kun JF, Kremsner PG (1998) Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria. J Infect Dis 178: 1221–4CrossRefPubMedGoogle Scholar
  34. Boldt AB, Luty A, Grobusch MP, Dietz K, Dzeing A, Kombila M, et al (2006) Association of a new mannose-binding lectin variant with severe malaria in Gabonese children. Genes Immun 7: 393–400CrossRefPubMedGoogle Scholar
  35. Uhlemann AC, Szlezák NA, Vonthein R, Tomiuk J, Emmer SA, Lell B, et al (2004) DNA phasing by TA dinucleotide microsatellite length determines in vitro and in vivo expression of the gp91phox subunit of NADPH oxidase and mediates protection against severe malaria. J Infect Dis 189: 2227–34CrossRefPubMedGoogle Scholar
  36. Lell B, May J, Schmidt-Ott RJ, Lehman LG, Luckner D, Greve B, et al (1999) The role of red blood cell polymorphisms in resistance and susceptibility to malaria. Clin Infect Dis 28: 794–9CrossRefPubMedGoogle Scholar
  37. Barragan A, Kremsner PG, Wahlgren M, Carlson J (2000) Blood group a antigen is a coreceptor in Plasmodium falciparum resetting. Infect Immun 68: 2971–5CrossRefPubMedPubMedCentralGoogle Scholar
  38. Missinou MA, Lell B, Kremsner PG (2003) Uncommon asymptomatic Plasmodium falciparum infections in Gabonese children. Clin Infect Dis 36: 1198–202CrossRefPubMedGoogle Scholar
  39. Greve B, Lehman LG, Lell B, Luckner D, Schmidt-Ott R, Kremsner PG (1999) High oxygen radical production is associated with fast parasite clearance in children with Plasmodium falciparum malaria. J Infect Dis 179:1584–6Google Scholar
  40. Luty AJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B, et al (1999) Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis 179: 980–8CrossRefPubMedGoogle Scholar
  41. van den Biggelaar AH, van Ree R, Rodrigues LC, Lell B, Deelder AM, Kremsner PG, et al (2000) Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 356: 1723–7CrossRefPubMedGoogle Scholar
  42. van den Biggelaar AH, Lopuhaa C, van Ree R, van der Zee JS, Jans J, Hoek A, et al (2001) The prevalence of parasite infestation and house dust mite sensitization in Gabonese schoolchildren. Int Arch Allergy Immunol 126: 231–8CrossRefPubMedGoogle Scholar
  43. van den Biggelaar AH, Rodrigues LC, van Ree R, van der Zee JS, Hoeksma-Kruize YC, Souverijn JH, et al (2004) Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese school children. J Infect Dis 189: 892–900CrossRefPubMedGoogle Scholar
  44. Lell B, Borrmann S, Yazdanbakhsh M, Kremsner PG (2001) Atopy and malaria. Wien Klin Wochenschr 113: 927–9PubMedGoogle Scholar
  45. Yazdanbakhsh M, Kremsner PG, van Ree R (2002) Allergy, parasites, and the hygiene hypothesis. Science 296: 490–4CrossRefPubMedGoogle Scholar
  46. van Riet E, Adegnika AA, Retra K, Vieira R, Tielens AG, Lell B, et al (2007) Cellular and humoral responses to influenza in gabonese children living in rural and semi-urban areas. J Infect Dis 196: 1671–8CrossRefPubMedGoogle Scholar
  47. Adegnika AA, Köhler C, Agnandji ST, Chai SK, Labuda L, Breitling LP, et al (2008) Pregnancy-associated malaria affects toll-like receptor ligand-induced cytokine responses in cord blood. J Infect Dis 198: 928–36CrossRefPubMedGoogle Scholar
  48. Köhler C, Adegnika AA, Van der Linden R, Agnandji ST, Chai SK, Luty AJ, et al (2008) Comparison of immunological status of African and European cord blood mononuclear cells. Pediatr Res 64: 631–6CrossRefPubMedGoogle Scholar
  49. Khattab A, Kun J, Deloron P, Kremsner PG, Klinkert MQ (2001) Variants of Plasmodium falciparum erythrocyte membrane protein 1 expressed by different placental parasites are closely related and adhere to chondroitin sulfate A. J Infect Dis 183: 1165–9CrossRefPubMedGoogle Scholar
  50. Winter G, Chen Q, Flick K, Kremsner P, Fernandez V, Wahlgren M (2003) The 3D7var5.2 (var COMMON) type var gene family is commonly expressed in non-placental Plasmodium falciparum malaria. Mol Biochem Parasitol 127: 179–91CrossRefPubMedGoogle Scholar
  51. Frank M, Kirkman L, Costantini D, Sanyal S, Lavazec C, Templeton TJ, et al (2008) Frequent recombination events generate diversity within the multi-copy variant antigen gene families of Plasmodium falciparum. Int J Parasitol 38: 1099–109CrossRefPubMedPubMedCentralGoogle Scholar
  52. Hübner MP, Pasche B, Kalaydjiev S, Soboslay PT, Lengeling A, Schulz-Key H, et al (2008) Microfilariae of the filarial nematode Litomosoides sigmodontis exacerbate the course of lipopolysaccharide-induced sepsis in mice. Infect Immun 76: 1668–77CrossRefPubMedPubMedCentralGoogle Scholar
  53. Issifou S, Kendjo E, Missinou MA, Matsiegui PB, Dzeing-Ella A, Dissanami FA, et al (2007) Differences in presentation of severe malaria in urban and rural Gabon. Am J Trop Med Hyg 77: 1015–19PubMedGoogle Scholar
  54. Schwarz NG, Oyakhirome S, Pötschke M, Gläser B, Klein Klouwenberg P, Altun H, et al (2005) 5-day nonobserved artesunate monotherapy for treating uncomplicated Falciparum malaria in young Gabonese children. Am J Trop Med Hyg 73: 705–9PubMedGoogle Scholar
  55. Kreidenweiss A, Kremsner PG, Mordmüller B (2008) Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon. Malar J 7: 187CrossRefPubMedPubMedCentralGoogle Scholar
  56. de Messias-Reason I, Kremsner PG, Kun JF (2009) Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy. J Infect Dis 199: 801–4CrossRefPubMedGoogle Scholar
  57. Song le H, Xuan NT, Toan NL, Binh VQ, Boldt AB, Kremsner PG, et al (2008) Association of two variants of the interferon-alpha receptor-1 gene with the presentation of hepatitis B virus infection. Eur Cytokine Netw 19: 204–10PubMedGoogle Scholar
  58. Tena-Tomás C, Pedroso ML, de Messias-Reason IJ, Kremsner PG, Kun JF (2007) Polymorphisms in the IFNAR1 gene in patients with chronic hepatitis C: outcome of combined IFN-alpha therapy. Eur Cytokine Netw 18: 136–41PubMedGoogle Scholar
  59. Lell B, Ruangweerayut R, Wiesner J, Missinou MA, Schindler A, Baranek T, et al (2003) Fosmidomycin, a novel chemotherapeutic agent for malaria. Antimicrob Agents Chemother 47: 735–8CrossRefPubMedPubMedCentralGoogle Scholar
  60. Mordmüller B, Kremsner PG (1998) Hyperparasitemia and blood exchange transfusion for treatment of children with falciparum malaria. Clin Infect Dis 26: 850–2CrossRefPubMedGoogle Scholar
  61. Mordmüller B, Fendel R, Kreidenweiss A, Gille C, Hurwitz R, Metzger WG, et al (2006) Plasmodia express two threonine-peptidase complexes during asexual development. Mol Biochem Parasitol 148: 79–85CrossRefPubMedGoogle Scholar
  62. Ntoumi F, Flori L, Mayengue PI, Matondo Maya DW, Issifou S, Deloron P, et al (2005) Influence of carriage of hemoglobin AS and the Fc gamma receptor IIa-R131 allele on levels of immunoglobulin G2 antibodies to Plasmodium falciparum merozoite antigens in Gabonese children. J Infect Dis 192: 1975–80CrossRefPubMedGoogle Scholar
  63. Mayengue PI, Luty AJ, Rogier C, Baragatti M, Kremsner PG, Ntoumi F (2009) The multiplicity of Plasmodium falciparum infections is associated with acquired immunity to asexual blood stage antigens. Microbes Infect 11: 108–14CrossRefPubMedGoogle Scholar
  64. Kocherscheidt L, Flakowski AK, Grüner B, Hamm DM, Dietz K, Kern P, et al (2008) Echinococcus multilocularis: inflammatory and regulatory chemokine responses in patients with progressive, stable and cured alveolar echinococcosis. Exp Parasitol 119: 467–74CrossRefPubMedGoogle Scholar
  65. Zanger P, Holzer J, Schleucher R, Steffen H, Schittek B, Gabrysch S (2009) Constitutive expression of the antimicrobial peptide RNase 7 is associated with Staphylococcus aureus infection of the skin. J Infect Dis 200:1907–15Google Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Institut für TropenmedizinEberhard-Karls-Universität TübingenTübingenGermany

Personalised recommendations